Skip to main content
. Author manuscript; available in PMC: 2015 Oct 15.
Published in final edited form as: Cancer Res. 2014 Aug 21;74(20):5855–5865. doi: 10.1158/0008-5472.CAN-14-0799

Table 1.

SAR405838 potently inhibits cell growth in cancer cell lines of diverse tumor types with wild-type p53 and displays high selectivity over cancer cell lines with mutated or deleted p53.

Cell Lines p53 status Cell growth Inhibition (IC50, μM)
SAR405838 MI-219 Nutlin-3a
SJSA-1 Wild Type 0.092±0.019 1.4 ± 0.2 1.3± 0.2
RS4;11 Wild Type 0.089±0.027 1.0 ± 0.2 0.57± 0.13
LANCaP Wild Type 0.27 ±0.03 1.1 ± 0.1 1.2 ± 0.4
HCT-116 Wild Type 0.20 ± 0.04 0.95 ± 0.05 0.86 ±0.11
HCT-116 (p53−/−) Deletion >20 >10 >10
SAOS-2 Deletion >10
PC-3 Deletion >10
SW620 Mutation >10